Stephen Chia Selected Research

Stephen Chia Research Topics

Disease

48	Breast Neoplasms (Breast Cancer) 09/2021 - 12/2003
27	Neoplasms (Cancer) 01/2022 - 11/2003
4	Pathologic Complete Response 12/2020 - 08/2009
4	Cardiotoxicity 01/2009 - 10/2005
3	Neutropenia 01/2021 - 01/2010
2	Carcinogenesis 09/2021 - 11/2005
2	Neoplasm Metastasis (Metastasis) 02/2021 - 05/2011
2	Disease Progression 01/2021 - 01/2019
2	Exanthema (Rash) 01/2017 - 09/2009
2	Brain Neoplasms (Brain Tumor) 06/2012 - 11/2009
1	Colorectal Neoplasms (Colorectal Cancer) 09/2021
1	Nausea 01/2020
1	Vomiting 01/2020
1	Hyperglycemia 11/2018
1	Leukopenia 01/2018
1	Triple Negative Breast Neoplasms 04/2012
1	Acidosis 05/2011
1	Hypoxia (Hypoxemia) 05/2011
1	Hypertension (High Blood Pressure) 01/2010
1	Gastrointestinal Hemorrhage (Hematochezia) 01/2010
1	Cough 09/2009
1	Anorexia 09/2009
1	Diarrhea 09/2009
1	Stomatitis 09/2009
1	Fatigue 09/2009
1	Pneumonia (Pneumonitis) 09/2009

Drug/Important Bio-Agent (IBA)

15	Hormones (Hormone)IBA 02/2021 - 04/2008
10	Fulvestrant (Faslodex)FDA Link 01/2021 - 04/2008
10	Trastuzumab (Herceptin)FDA Link 11/2019 - 04/2004
8	Biomarkers (Surrogate Marker)IBA 09/2021 - 08/2009
7	Estrogen ReceptorsIBA 01/2022 - 12/2003
7	Aromatase InhibitorsIBA 01/2021 - 04/2008
6	ErbB Receptors (EGF Receptor)IBA 01/2022 - 04/2004
6	Pharmaceutical PreparationsIBA 01/2020 - 06/2005
4	N-acetyltalosaminuronic acid (NAT)IBA 01/2020 - 03/2014
4	human ERBB2 proteinIBA 01/2020 - 12/2008
4	Proteins (Proteins, Gene)FDA Link 05/2011 - 11/2003
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 06/2004
3	Paclitaxel (Taxol)FDA LinkGeneric 09/2021 - 12/2003
3	Epidermal Growth Factor (EGF)IBA 02/2021 - 01/2017
3	exemestane (Aromasin)FDA Link 01/2019 - 04/2008
3	AnthracyclinesIBA 01/2018 - 01/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2009 - 06/2005
3	liposomal doxorubicin (Doxil)FDA Link 08/2007 - 06/2005
2	Phenobarbital (Luminal)FDA Link 01/2022 - 05/2015
2	Bevacizumab (Avastin)FDA Link 09/2021 - 06/2012
2	Everolimus FDA Link 09/2021 - 09/2009
2	AlpelisibIBA 01/2021 - 01/2021
2	Cyclin-Dependent Kinase 4IBA 01/2021 - 01/2021
2	ribociclibIBA 01/2020 - 01/2018
2	Carbonic Anhydrase IXIBA 01/2020 - 05/2011
2	Immune Checkpoint InhibitorsIBA 11/2019 - 08/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 06/2004
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2018 - 01/2017
2	Alanine Transaminase (SGPT)IBA 11/2018 - 01/2017
2	NVP-BKM120IBA 11/2018 - 01/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2018 - 01/2017
2	pertuzumabIBA 01/2018 - 07/2014
2	PlatinumIBA 12/2017 - 08/2009
2	RNA (Ribonucleic Acid)IBA 10/2015 - 02/2006
2	Fluorouracil (Carac)FDA LinkGeneric 01/2012 - 04/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012 - 04/2009
2	ParaffinIBA 01/2012 - 06/2004
2	Formaldehyde (Formol)FDA Link 01/2012 - 06/2004
2	Docetaxel (Taxotere)FDA Link 04/2009 - 01/2009
2	1-dodecylpyridoxal (PLD)IBA 08/2007 - 06/2006
2	Drug CombinationsIBA 06/2005 - 04/2004
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2021
1	Capecitabine (Xeloda)FDA Link 09/2021
1	neratinibIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	SLC-0111IBA 01/2020
1	BenzenesulfonamidesIBA 01/2020
1	durvalumabIBA 11/2019
1	B7-H1 AntigenIBA 11/2019
1	Circulating Tumor DNAIBA 01/2019
1	thymidine kinase 1IBA 01/2019
1	Coloring Agents (Dyes)IBA 05/2015
1	taxaneIBA 03/2014
1	Monoclonal AntibodiesIBA 06/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2012
1	Epirubicin (Ellence)FDA LinkGeneric 01/2012
1	Methotrexate (Mexate)FDA LinkGeneric 01/2012
1	Small Interfering RNA (siRNA)IBA 05/2011
1	CaspasesIBA 05/2011
1	pazopanib FDA Link 01/2010
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2010
1	TOR Serine-Threonine KinasesIBA 09/2009
1	Biological ProductsIBA 09/2009
1	OGX-011IBA 01/2009

Therapy/Procedure

21	Therapeutics 09/2021 - 08/2007
11	Drug Therapy (Chemotherapy) 09/2021 - 01/2009
6	Neoadjuvant Therapy 12/2020 - 03/2014
1	Drug Tapering 01/2021
1	Operative Time 01/2021
1	Mastectomy (Mammectomy) 12/2020
1	Segmental Mastectomy (Lumpectomy) 12/2020
1	Immunotherapy 08/2019